Venlafaxine in the treatment of postpartum depression

Journal of Clinical Psychiatry

Volumn 62, Issue 8, 2001, Pages 592-596

  Cohen, L S ^a   Viguera, A C ^a   Bouffard, S M ^a   Nonacs, R M ^a   Morabito, C ^a   Collins, M H ^a   Ablon, J S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VENLAFAXINE;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; EARLY DIAGNOSIS; FEMALE; HAMILTON SCALE; HIGH RISK PATIENT; HUMAN; MORBIDITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUERPERAL DEPRESSION; QUESTIONNAIRE;

EID: 0034856694     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0803     Document Type: Article

References (36)

1. Controlled prospective study of postpartum mood disorders: Psychological, environmental, and hormonal factors
2. A prospective study of emotional disorders in childbearing women
3. A controlled study of the onset, duration, and prevalence of postnatal depression
4. Prospective study of postpartum depression: Prevalence, course, and predictive factors
5. Non-psychotic psychiatric disorder after childbirth: A prospective study of prevalence, incidence, course and nature
6. Ten-year cumulative probability of recurrence after recovery from an index episode of MDD
7. Sertraline in the treatment of women with postpartum major depression
8. A controlled study of fluoxetine and cognitive-behavioral counseling in the treatment of postnatal depression
9. Transdermal oestrogen for treatment of severe postnatal depression
10. Treatment of postpartum depression with interpersonal psychotherapy
11. Efficacy of interpersonal psychotherapy for postpartum depression
12. Progesterone prophylaxis used successfully in postnatal depression
13. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression
14. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: A dose-response study
15. Venlafaxine in treatment-resistant major depression: A Canadian multicenter, open-label trial
16. A rating scale for depression
17. A symptom questionnaire
18. Pharmacologic management of psychiatric illness during pregnancy and the postpartum period
19. Postpartum and nonpostpartum depression: Differences in presentation and response to pharmacologic treatment
20. Prospective study of the psychiatric disorders of childbirth
21. Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk
22. Maternal depression and infant maladjustment: A failure of mutual regulation
23. Impact of maternal depression on cognitive development of young children
24. The impact of postnatal depression on infant development
25. Maternal depression and child development
26. Predictors of relapse in major depressive disorder
27. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
28. Long-term outcome of episodes of major depression: Clinical and public health significance
29. "Atypical" depression following childbirth
30. Course of panic disorder during pregnancy and the puerperium: A preliminary study
31. Postpartum psychiatric syndromes
32. Postpartum mood disorders: Diagnosis and treatment guidelines
33. Efficacy of once-daily venlafaxine (XR) for symptoms of anxiety in depressed outpatients
34. Venlafaxine XR is an efficacious short- and long-term treatment for generalized anxiety disorder